tiprankstipranks
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market
NDRA
ENDRA Life Sciences
RESEARCH TOOLSreports

ENDRA Life Sciences (NDRA) Financial Statements

855 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently $6.63M. The company's EPS TTM is $-3.26; its P/E ratio is -0.51; ENDRA Life Sciences is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -275.45K$ -234.26K$ -224.41K
Operating Income$ -5.76M$ -10.82M$ -10.52M$ -13.16M$ -11.50M
EBITDA$ -5.61M$ -10.77M$ -9.78M$ -12.94M$ -11.01M
Net Income$ -7.03M$ -11.51M$ -10.06M$ -13.18M$ -11.23M
Balance Sheet
Cash & Short-Term Investments$ 762.37K$ 3.23M$ 2.83M$ 4.89M$ 9.46M
Total Assets$ 3.85M$ 4.45M$ 6.75M$ 9.27M$ 12.87M
Total Debt$ 492.35K$ 584.42K$ 394.40K$ 546.63K$ 796.09K
Net Debt$ -270.01K$ -2.65M$ -2.44M$ -4.34M$ -8.67M
Total Liabilities$ 1.59M$ 1.89M$ 1.10M$ 2.07M$ 2.09M
Stockholders' Equity$ 2.26M$ 2.56M$ 5.66M$ 7.20M$ 10.78M
Cash Flow
Free Cash Flow$ -5.20M$ -7.42M$ -9.58M$ -12.97M$ -11.17M
Operating Cash Flow$ -5.18M$ -7.40M$ -9.55M$ -12.77M$ -11.12M
Investing Cash Flow$ -3.02M$ -12.80K$ -24.72K$ -202.58K$ -45.00K
Financing Cash Flow$ 5.73M$ 7.81M$ 7.52M$ 8.40M$ 13.40M
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

Income Statement >

ENDRA Life Sciences Debt to Assets

Balance Sheet >

ENDRA Life Sciences Cash Flow

Cash Flow >

ENDRA Life Sciences Forecast EPS vs Actual EPS

Earnings >